Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2017

Study Completion Date

May 29, 2020

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy

SBRT involves highly precise delivery of very high dose Radiotherapy (RT) over a very few fractions (hypofractionation) to accurately delineated, size-restricted malignant targets in which motion has been accounted for during the delivery process. SBRT administration achieves avoidance of normal tissue exposure to radiation during the planning process, by providing for sharp fall-off dose gradients outside the target.

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01480973 - Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter